Xeris Biopharma Holdings, Inc. (XERS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $369.84M | +4.9% |
| 2024 | $352.68M | +7.1% |
| 2023 | $329.38M | +10.0% |
| 2022 | $299.33M | +43.1% |
| 2021 | $209.13M | +66.8% |
| 2020 | $125.39M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $369.84M | +4.9% |
| 2024 | $352.68M | +7.1% |
| 2023 | $329.38M | +10.0% |
| 2022 | $299.33M | +43.1% |
| 2021 | $209.13M | +66.8% |
| 2020 | $125.39M | — |